I'm not a holder, but OPT did a deal with a group called Carlyle Abbingworth/LaunchTx whereby they stumped up 170mill cash to fund P3 trials, and are then entitled to a % of profits if the product gets to market, (something like 7% of annual sales) capped at 4x their initial investment.. if the trials fail, the debt is wiped.
There would be lots of variations on this kind of arrangement available to NEU, through multiple interested parties I'm guessing. Remember we brought on Jefferies as a strategic advisor last year, we didn't do that for no reason. We're in good hands I'd say, JP and co know what they're sitting on.
I'm not a holder, but OPT did a deal with a group called Carlyle...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |